[ad_1]
Number of new cases in 14 days 100 thousand. population was reduced to 16, the proportion of positive diagnostic tests is 0.5 percent.
The country underwent 2,562 molecular tests (PCR) and 1,569 antigens for suspected coronavirus.
In Lithuania, since the start of the pandemic, COVID-19 has affected 278,984 people, of which it was still reduced to 490.
A total of 4,395 people died from the disease, with 8,947 deaths directly and indirectly related to COVID-19.
Lithuanian hospitals are currently treating 81 COVID-19 patients, 17 of them in resuscitation, Statistics Lithuania reported on Wednesday.
Compared with the previous day, the number of patients in medical institutions decreased by 30.
Oxygen is added to 57 patients and 12 patients receive artificial lung ventilation.
Two people were hospitalized for COVID-19 each day.
In Lithuania, since the start of the pandemic, COVID-19 has affected 278,984 people.
To date, a total of 4,395 people have died from the disease, with 8,947 deaths directly and indirectly related to COVID-19.
During the last day, 1,238 people received the first dose of the vaccine, and the second – 3,232, the Department of Statistics announced on Wednesday.
In the country, COVID-19 has been used to vaccinate at least 258,539 people, both – 1 million. 40 thousand. 852.
At least one dose of the vaccine was 54.3%. more than 80, 68.8 percent. – Population from 75 to 79 years old, 71.1 percent. – 70-74 years and 69.7 percent. – Population from 65 to 69 years old.
In the 55 to 64 age group, 58% are vaccinated, in the 45 to 54 age group 51.6%, in the 35 to 44 age group, 49.9% in the 25 age group to 34 years, 43.1%, in those of 16 to 24 years. age group – 41.1 percent. population. 8.7 percent of children aged 12 to 15 were vaccinated.
In Lithuania, 45% have received at least one coronavirus vaccine. people.
In total, Lithuania has received 3 million. 44,155 doses of vaccines, of which 2 million were used. 299,391 doses of vaccine.
Currently 745 thousand unused. vaccine dose.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to cite DELFI as the source.
[ad_2]
